April 8, 2015
The Alliance for Patient Access (AfPA) today announced that it will now manage www.PrescriptionProcess.com, an online resource for patients to learn, share stories and advocate about access to approved medical therapies.
April 7, 2015
A new study from the Food and Drug Law Journal argues that fewer restrictions on communication between pharmaceutical companies and physicians would foster better-informed prescribing decisions.
April 2, 2015
In a new BIOtechNOW blog post, Coalition for Clinical Trials Awareness (CCTA) steering committee members explain how stalled clinical trials stifle patients’ hope for breakthrough medicines.
March 31, 2015
State legislatures across the country are considering bills to ensure that physicians know when a pharmacist swaps a prescribed biologic medicine for a new “biosimilar.”
March 25, 2015
As most Americans now realize, abuse of prescription pain medication presents a formidable challenge.
March 24, 2015
Will the labels used for biosimilars help – or hinder – the adoption of these new medications?
March 23, 2015
Chronic pain’s multifaceted symptoms require a multidisciplinary approach to care, says the Institute for Patient Access’ new policy brief. Yet several barriers may prevent chronic pain patients from finding the long-term relief they need.
March 20, 2015
A new oncology payment model rewards “value of care, not volume” says the Centers for Medicare and Medicaid Services.
March 9, 2015
On Friday the Food and Drug Administration approved the United States’ first biosimilar medicine.
March 5, 2015
Patients co-infected with hepatitis C and HIV may have newfound hope. Clinical trial results presented at the 2015 Conference on Retroviruses and Opportunistic Infections show that a new combination pill worked for co-infected patients of certain genotypes 96 percent of the time.
